Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Mesothelioma, Malignant 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Esophageal Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumor 1Pleural Effusion, Malignant 1Neoplasm Metastasis 1Malignant Solid Tumor 1

Interventions

aldesleukin 2Pharmaceutical Preparations 2Interleukin-2 2Valacyclovir 1Thoracoscopy 1Thiostrepton 1Talc 1One-Lung Ventilation 1LMB-100 1Decitabine 1Cytoreduction Surgical Procedures 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion, Malignant × Decitabine × Other solid neoplasm × Clear all
NCT00019825 2015-04-29

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

National Cancer Institute (NCI)

Phase 1 Completed
GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡